ZOHYDRO ER
Total Payments
$1.6M
Transactions
17,218
Doctors
4,418
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $28,326 | 5 | 3 |
| 2019 | $23,865 | 99 | 85 |
| 2018 | $597,674 | 7,109 | 2,152 |
| 2017 | $917,087 | 10,005 | 3,467 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $676,280 | 336 | 43.2% |
| Food and Beverage | $310,755 | 15,921 | 19.8% |
| Consulting Fee | $202,778 | 96 | 12.9% |
| Travel and Lodging | $177,800 | 687 | 11.3% |
| Honoraria | $101,129 | 62 | 6.5% |
| Unspecified | $98,067 | 112 | 6.3% |
| Education | $143.47 | 4 | 0.0% |
Payments by Type
General
$1.5M
17,106 transactions
Research
$98,067
112 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ERLA Opioid PMR Requirements Clinical Study | Pernix Therapeutics Holdings, Inc. | $51,932 | 0 |
| ER/LA Opioid PMR - Observational Study 1B | Persion Pharmaceuticals LLC | $23,347 | 0 |
| ERLA Opioid PMR - Observational Study 1B | Persion Pharmaceuticals LLC | $11,453 | 0 |
| ERLA Opioid REMS | Pernix Therapeutics Holdings, Inc. | $6,525 | 0 |
| OPC - 5 Investigator Meeting 2 for Protocol 2065-5 | Pernix Therapeutics Holdings, Inc. | $3,792 | 0 |
| OPC - 5 Investigator Meeting for Protocol 2065-5 | Pernix Therapeutics Holdings, Inc. | $1,018 | 0 |
Top Doctors Receiving Payments for ZOHYDRO ER
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Mark Carducci | — | Laramie, WY | $98,518 | 129 |
| , M.D | Anesthesiology | New York, NY | $92,315 | 110 |
| , M.D | Interventional Pain Medicine | Deer Park, IL | $86,624 | 111 |
| , MD | Physical Medicine & Rehabilitation | Overland Park, KS | $61,172 | 72 |
| , M.D | Pain Medicine | Anniston, AL | $58,370 | 95 |
| , M.D | Pain Medicine | Santa Monica, CA | $57,618 | 84 |
| , M.D., MPH | Internal Medicine | Marietta, GA | $48,897 | 84 |
| , MD | Anesthesiology | Saint Louis, MO | $43,684 | 51 |
| , M.D | Physical Medicine & Rehabilitation | Chester, NJ | $30,737 | 80 |
| , M.D | Pain Medicine | Allentown, PA | $28,939 | 46 |
| Hans Hansen | — | Conover, NC | $27,417 | 63 |
| , M.D | Physical Medicine & Rehabilitation | Lambertville, MI | $26,397 | 66 |
| , MD | Physical Medicine & Rehabilitation | Lakewood, CO | $25,991 | 56 |
| , M.D | Pain Medicine | Jacksonville, FL | $25,803 | 44 |
| , M.D | Anesthesiology | Oak Brook, IL | $24,134 | 59 |
| , M.D | Anesthesiology | Merritt Island, FL | $24,021 | 58 |
| , MD | Pain Medicine | Cleveland, OH | $23,637 | 47 |
| , MD | Interventional Pain Medicine | Pikesville, MD | $22,927 | 59 |
| , M.D | Specialist | Atlanta, GA | $22,026 | 42 |
| , MD | Physical Medicine & Rehabilitation | Pottstown, PA | $21,904 | 46 |
| , D.O | Physical Medicine & Rehabilitation | La Jolla, CA | $21,551 | 65 |
| , M.D | Pain Medicine | Saint Louis, MO | $21,253 | 68 |
| , M.D | Pain Medicine | Huntington Beach, CA | $21,099 | 46 |
| , MD | Interventional Pain Medicine | Syosset, NY | $21,096 | 45 |
| , MD | Physical Medicine & Rehabilitation | Overland Park, KS | $19,647 | 25 |
Ad
Manufacturing Companies
- Pernix Therapeutics Holdings, Inc. $1.5M
- Persion Pharmaceuticals LLC $42,588
- Currax Pharmaceuticals LLC $3,500
Product Information
- Type Drug
- Total Payments $1.6M
- Total Doctors 4,418
- Transactions 17,218
About ZOHYDRO ER
ZOHYDRO ER is a drug associated with $1.6M in payments to 4,418 healthcare providers, recorded across 17,218 transactions in the CMS Open Payments database. The primary manufacturer is Pernix Therapeutics Holdings, Inc..
Payment data is available from 2017 to 2020. In 2020, $28,326 was paid across 5 transactions to 3 doctors.
The most common payment nature for ZOHYDRO ER is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($676,280, 43.2% of total).
ZOHYDRO ER is associated with 6 research studies, including "ERLA Opioid PMR Requirements Clinical Study" ($51,932).